Anna Eshoo actually said...

I think that the committee needs to take that into consideration.

I see, as I expressed to you when we spoke, a disconnect between CMS, the FDA, and the VA on new treatments for mild Alzheimer's.

We need to get a clear explanation from hospitals on why, after hospitals acquire physician practices, the prices for the services provided ...

The Medicaid Value-Based Payments for Patients Act will codify a CMS rule to help ensure Medicaid enrollees have access to breakthrough gene...